TWA
CDMO

TCI Wealth Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

TCI Wealth Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-228
Closed -$3.14K – 2662
2022
Q4 		$3.14K Buy
+228
New +$3.49K ﹤0.01% 1837
2022
Q2 		– Sell
-154
Closed -$3K – 2563
2022
Q1 		$3K Hold
154
– – ﹤0.01% 1932
2021
Q4 		$4K Hold
154
– – ﹤0.01% 1937
2021
Q3 		$3K Hold
154
– – ﹤0.01% 2047
2021
Q2 		$4K Buy
154
+37
+32% +$790 ﹤0.01% 1661
2021
Q1 		$2K Buy
+117
New +$1.94K ﹤0.01% 1942

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

TCI Wealth Advisors's CDMO Position: Q1 2023 in Review

TCI Wealth Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2023, closing a stake of 228 shares — an estimated $3.14K sold.

TCI Wealth Advisors first reported a position in CDMO in Q1 2021 and held it in 6 quarters. The position peaked at $4K in Q4 2021. 168 funds tracked by Wall St. Rank hold CDMO as of Q1 2023.

  • TCI Wealth Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 228 Avid Bioservices, Inc. Common Stock shares in Q1 2023, an estimated $3.14K.
  • TCI Wealth Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
  • TCI Wealth Advisors's Avid Bioservices, Inc. Common Stock position peaked at $4K in Q4 2021.
  • 168 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2023.

Based on TCI Wealth Advisors's 13F filing for Q1 2023, filed 3 May 2023.